US Edition
Vext Science is a buy, Ventum Capital says
Summary by Cantech Letter
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Vext Science is a buy, Ventum Capital says
In a May 21 update, Ventum Capital Markets analyst Andrew Semple maintained a “Buy” rating and $0.50 target for Vext Science (Vext Science Stock Quote, Chart, News, Analysts, Financials CSE:VEXT), citing stronger-than-expected cash flow and improving liquidity. Vext reported $3.1-million in operating cash flow for the quarter, well above the forecasted $0.5-million, which helped reduce […] Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
